Answer
Umeclidinium bromide is contraindicated in people with hypersensitivity to the active substance or any excipient listed in section 6.1 of its product information.
Sources for this answer
- Incruse Ellipta 55 micrograms inhalation powder, pre-dispensedGlaxoSmithKline UK · emc · SmPC §4.3 Contraindications · Version 18Document updated
Sources checked